Betting on Better Organs

Betting on Better Organs © 3D4medical.com Will you soon be able to buy your own bladder? By Alison McCook Related Articles 1 Patients are left with less tissue to function as intestine, which can complicate things even further. Some studies have also linked the procedure to a slightly higher risk of cancer. Performing this procedure in older adults, who have relatively fewer years left to develop complications, is one thing. But what

Written byAlison McCook
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

By Alison McCook

1 Patients are left with less tissue to function as intestine, which can complicate things even further. Some studies have also linked the procedure to a slightly higher risk of cancer.

Performing this procedure in older adults, who have relatively fewer years left to develop complications, is one thing. But what about the children who could live with jerry-rigged bladders for decades? This is a question Anthony Atala asked himself as a surgical resident training in pediatric urology. "These children had an 80-year life expectancy," he says. "They are going to have a lot of problems."

The ideal solution, Atala reasoned, was to provide children with new tissue from their bladders, not their intestines. This meant growing a vast amount of new, autologous bladder cells. In 1990, out of "pure ignorance" of how hard it would be, Atala started experimenting with biopsies, media, and scaffolds. Naturally, this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies